True Wealth Design’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43K | Buy |
342
+316
| +1,215% | +$39.7K | 0.02% | 222 |
|
|
2025
Q1 | $2.88K | Sell |
26
-418
| -94% | -$46.2K | ﹤0.01% | 879 |
|
|
2024
Q4 | $60.6K | Sell |
444
-148
| -25% | -$20.2K | 0.02% | 133 |
|
|
2024
Q3 | $68.2K | Buy |
592
+587
| +11,740% | +$67.6K | 0.03% | 88 |
|
|
2024
Q2 | $689 | Buy |
5
+2
| +67% | +$276 | ﹤0.01% | 598 |
|
|
2024
Q1 | $414 | Buy |
3
+1
| +50% | +$138 | ﹤0.01% | 666 |
|
|
2023
Q4 | $264 | Hold |
2
| – | – | ﹤0.01% | 635 |
|
|
2023
Q3 | $225 | Hold |
2
| – | – | ﹤0.01% | 617 |
|
|
2023
Q2 | $189 | Hold |
2
| – | – | ﹤0.01% | 658 |
|
|
2023
Q1 | $203 | Hold |
2
| – | – | ﹤0.01% | 727 |
|
|
2022
Q4 | $239 | Buy |
+2
| New | +$239 | ﹤0.01% | 636 |
|